S. 694In Committee
PLASMA Act
Phases in Medicare Part D manufacturer discount requirements for plasma-derived products over several years
Plain-English overview
What this bill does
Phases in Medicare Part D manufacturer discount requirements for plasma-derived products over several years
Key points
- Modify plasma product discounts
- Extend discount phase in schedule
Current status
Where it stands
Status
In Committee
Latest action
2025-02-24 — Read twice and referred to the Committee on Finance.
Related context
Topics and policy areas
undefinedBlood and blood diseasesDrug therapyHealthHealth care costs and insuranceManufacturingMedicarePrescription drugs